Oral eplerenone for the management of chronic central serous chorioretinopathy

AIM: To examine eplerenone (Inspra, Pfizer), a mineralocorticoid receptor antagonist, as a treatment option for chronic central serous chorioretinopathy (CSCR). METHODS: A retrospective consecutive case series was conducted for patients receiving oral eplerenone for chronic CSCR. At baseline and eac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Ophthalmol
Autors principals: Singh, Rishi P, Sears, Jonathan E, Bedi, Rumneek, Schachat, Andrew P, Ehlers, Justis P, Kaiser, Peter K
Format: Artigo
Idioma:Inglês
Publicat: International Journal of Ophthalmology Press 2015
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413566/
https://ncbi.nlm.nih.gov/pubmed/25938046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3980/j.issn.2222-3959.2015.02.17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars